Heidi Miller
Family · Houston, TXNPI 1225742208
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 24.8% of the total. 2025 is the largest year on record at $2,189, 2.2 times the $987 reported in 2023. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$1K
- Abbott$738
- Impulse Dynamics (USA) Inc.$543
- Merck$463
- Bayer$396
- United Therapeutics Corporation$294
- plus $1K from 16 others
What the payments were for
- Travel & lodging$2385%
- Food & beverage$4,43895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 31 | $1,158 |
| Abbott | 11 | $738 |
| Impulse Dynamics (USA) Inc. | 8 | $543 |
| Merck | 23 | $463 |
| Bayer | 16 | $396 |
| United Therapeutics Corporation | 13 | $294 |
| AstraZeneca | 8 | $269 |
| Boehringer Ingelheim | 8 | $152 |
| Scpharmaceuticals Inc. | 6 | $116 |
| Daiichi Sankyo Inc. | 5 | $116 |
| Novartis | 3 | $78 |
| Bridgebio Pharma, Inc. | 3 | $73 |
| Pfizer | 3 | $53 |
| Lexicon Pharmaceuticals, Inc. | 3 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Abiomed | 1 | $34 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $28 |
| Baxter Healthcare | 1 | $22 |
| Sandoz | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Mannkind Corporation | 1 | $16 |
| Cvrx, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,676 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WinrevairSotatercept-Csrk | 22 | $463,893 |
| OpsumitMacitentan | 33 | $430,827 |
| Tyvaso DpiTreprostinil | 15 | $352,290 |
| AdempasRiociguat | 18 | $229,384 |
| FuroscixFurosemide | 22 | $159,368 |
| EntrestoSacubitril/Valsartan | 74 | $66,540 |
| JardianceEmpagliflozin | 78 | $52,026 |
| EliquisApixaban | 33 | $32,098 |
| FarxigaDapagliflozin Propanediol | 23 | $21,385 |
| XareltoRivaroxaban | 14 | $10,921 |
| VerquvoVericiguat | 11 | $7,276 |
| Metoprolol Succinate | 37 | $850 |
| Bumetanide | 20 | $588 |
| Spironolactone | 41 | $494 |
| Atorvastatin Calcium | 47 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckWinrevair, Verquvo | $463 | $471,16933 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $1,158 | $430,82733 claims |
| BayerAdempas | $396 | $229,38418 claims |
| Scpharmaceuticals Inc.Furoscix | $116 | $159,36822 claims |
| NovartisEntresto | $78 | $66,54074 claims |
| Boehringer IngelheimJardiance | $152 | $52,02678 claims |
| PfizerEliquis | $53 | $32,09833 claims |
| AstraZenecaFarxiga | $269 | $21,38523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.